Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
Authors
Keywords
-
Journal
Addiction Science & Clinical Practice
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-10
DOI
10.1186/s13722-021-00277-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- “Like Yin and Yang”
- (2020) Robin Baker et al. Journal of Addiction Medicine
- Searching for qualitatively driven mixed methods research: a citation analysis
- (2020) David L. Morgan et al. QUALITY & QUANTITY
- Provider Perspectives on Integration of Substance Use Disorder and HIV Care in Vietnam: A Qualitative Study
- (2020) Andrew Edsall et al. JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH
- Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities
- (2019) Ramin Mojtabai et al. HEALTH AFFAIRS
- Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Barbara R Haight et al. LANCET
- Medication Treatment of Opioid Use Disorder
- (2019) James Bell et al. BIOLOGICAL PSYCHIATRY
- Initiating buprenorphine treatment for opioid use disorder during short‐term in‐patient ‘detoxification’: a randomized clinical trial
- (2019) Michael Stein et al. ADDICTION
- Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial
- (2019) Kim A. Hoffman et al. BMC HEALTH SERVICES RESEARCH
- Opioid use disorder and treatment: challenges and opportunities
- (2019) Kim A. Hoffman et al. BMC HEALTH SERVICES RESEARCH
- Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
- (2018) Rebecca L. Haffajee et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
- (2018) Joshua D Lee et al. LANCET
- Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence
- (2017) Lars Tanum et al. JAMA Psychiatry
- American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
- (2015) Kyle Kampman et al. Journal of Addiction Medicine
- Intentional Non-Adherence to Medications among HIV Positive Alcohol Drinkers: Prospective Study of Interactive Toxicity Beliefs
- (2012) Seth C. Kalichman et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Association Between Alcohol Use and HIV Viral Load
- (2011) Evan S Wu et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
- (2011) Evgeny Krupitsky et al. LANCET
- A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization
- (2010) Marwan M. Azar et al. DRUG AND ALCOHOL DEPENDENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started